| Year |
Citation |
Score |
| 2023 |
Raskin M, Malone C, Hilz EN, Smits JAJ, Telch MJ, Otto MW, Shumake J, Lee HJ, Monfils MH. CO reactivity is associated with individual differences in appetitive extinction memory. Physiology & Behavior. 114183. PMID 37031791 DOI: 10.1016/j.physbeh.2023.114183 |
0.555 |
|
| 2022 |
Smits JAJ, Monfils MH, Otto MW, Telch MJ, Shumake J, Feinstein JS, Khalsa SS, Cobb AR, Parsons EM, Long LJ, McSpadden B, Johnson D, Greenberg A. CO reactivity as a biomarker of exposure-based therapy non-response: study protocol. Bmc Psychiatry. 22: 831. PMID 36575425 DOI: 10.1186/s12888-022-04478-x |
0.556 |
|
| 2021 |
Powers MB, Carl E, Levihn-Coon A, Van Veldhuizen M, Caven A, Pogue J, Fresnedo M, Turner ED, Adams M, Leonard K, Conroy H, Lantrip C, Caven T, Isbell C, Regner J, ... ... Otto MW, et al. Non-pharmacologic Pain Management among Hospitalized Inpatients: A Randomized Waitlist Controlled Trial of Standard Virtual Reality (CGI VR) versus Video Capture VR (360° 3D/Stereoscopic Video Capture VR). The Clinical Journal of Pain. PMID 34265789 DOI: 10.1097/AJP.0000000000000958 |
0.656 |
|
| 2020 |
Stathopoulou G, Gold AK, Hoyt DL, Milligan M, Hearon BA, Otto MW. Does anxiety sensitivity predict addiction severity in opioid use disorder? Addictive Behaviors. 112: 106644. PMID 32987306 DOI: 10.1016/J.Addbeh.2020.106644 |
0.783 |
|
| 2020 |
Conroy HE, Jacquart J, Baird SO, Rosenfield D, Davis ML, Powers MB, Frierson GM, Marcus BH, Otto MW, Zvolensky MJ, Smits JAJ. Age and pre quit-day attrition during smoking cessation treatment. Cognitive Behaviour Therapy. 1-13. PMID 32343190 DOI: 10.1080/16506073.2020.1751262 |
0.543 |
|
| 2019 |
Gold AK, Stathopoulou G, Otto MW. Emotion regulation and motives for illicit drug use in opioid-dependent patients. Cognitive Behaviour Therapy. 1-7. PMID 30760111 DOI: 10.1080/16506073.2019.1579256 |
0.788 |
|
| 2018 |
Otto MW, Pachas GN, Cather C, Hoeppner SS, Moshier SJ, Hearon BA, Ward HB, Laffer AB, Smits JAJ, Evins AE. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation. Cognitive Behaviour Therapy. 1-12. PMID 30111253 DOI: 10.1080/16506073.2018.1476908 |
0.684 |
|
| 2018 |
Zvolensky MJ, Rosenfield D, Garey L, Kauffman BY, Langdon KJ, Powers MB, Otto MW, Davis ML, Marcus BH, Church TS, Frierson GM, Hopkins LB, Paulus DJ, Baird SO, Smits JAJ. Does exercise aid smoking cessation through reductions in anxiety sensitivity and dysphoria? Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. PMID 29708388 DOI: 10.1037/Hea0000588 |
0.546 |
|
| 2018 |
Stathopoulou G, Pollack MH, Otto MW. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addictive Behaviors. 84: 75-78. PMID 29631093 DOI: 10.1016/J.Addbeh.2018.03.020 |
0.773 |
|
| 2017 |
Deckersbach T, Peters AT, Shea C, Gosai A, Stange JP, Peckham AD, Ellard KK, Otto MW, Rauch SL, Dougherty DD, Nierenberg AA. Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging. Journal of Affective Disorders. 229: 342-350. PMID 29331692 DOI: 10.1016/J.Jad.2017.12.041 |
0.626 |
|
| 2017 |
Jacquart J, Papini S, Davis ML, Rosenfield D, Powers MB, Frierson GM, Hopkins LB, Baird SO, Marcus BH, Church TS, Otto MW, Zvolensky MJ, Smits JA. Identifying attendance patterns in a smoking cessation treatment and their relationships with quit success. Drug and Alcohol Dependence. 174: 65-69. PMID 28315809 DOI: 10.1016/J.Drugalcdep.2017.01.007 |
0.537 |
|
| 2016 |
Hearon BA, Beard C, Kopeski LM, Smits JA, Otto MW, Björgvinsson T. Attending to Timely Contingencies: Promoting Physical Activity Uptake Among Adults with Serious Mental Illness with an Exercise-For-Mood vs. an Exercise-For-Fitness Prescription. Behavioral Medicine (Washington, D.C.). 0. PMID 28027010 DOI: 10.1080/08964289.2016.1276428 |
0.68 |
|
| 2016 |
Farris SG, Davis ML, Rosenfield D, Kauffman BY, Baird SO, Powers MB, Otto MW, Marcus BH, Church TS, Smits JA, Zvolensky MJ. Exercise Self-Efficacy Moderates the Relation between Anxiety Sensitivity and Body Mass Index and Exercise Tolerance in Treatment-Seeking Smokers. Mental Health and Physical Activity. 10: 25-32. PMID 27725844 DOI: 10.1016/J.Mhpa.2016.05.001 |
0.57 |
|
| 2016 |
Powers MB, Davis ML, Kauffman BY, Baird SO, Zvolensky M, Rosenfield D, Marcus BH, Church TS, Frierson G, Otto MW, Smits JA. Anxiety sensitivity and smoking variability among treatment seeking smokers. Addictive Disorders & Their Treatment. 15: 136-142. PMID 27672353 DOI: 10.1097/Adt.0000000000000075 |
0.53 |
|
| 2016 |
Otto MW, Eastman A, Lo S, Hearon BA, Bickel WK, Zvolensky M, Smits JA, Doan SN. Anxiety sensitivity and working memory capacity: Risk factors and targets for health behavior promotion. Clinical Psychology Review. 49: 67-78. PMID 27611632 DOI: 10.1016/J.Cpr.2016.07.003 |
0.686 |
|
| 2016 |
Smits JA, Powers MB, Rosenfield D, Zvolensky MJ, Jacquart J, Davis ML, Beevers CG, Marcus BH, Church TS, Otto MW. BDNF Val66Met Polymorphism as a Moderator of Exercise Enhancement of Smoking Cessation Treatment in Anxiety Vulnerable Adults. Mental Health and Physical Activity. 10: 73-77. PMID 27453731 DOI: 10.1016/J.Mhpa.2016.01.001 |
0.566 |
|
| 2016 |
Otto MW, Lee J, Hofmann SG, Hearon BA, Smits JA, Rosenfield D, Fava M, Wright JH. Examining the Efficacy of D-cycloserine to Augment Therapeutic Learning in Depression. Contemporary Clinical Trials. PMID 27094721 DOI: 10.1016/J.Cct.2016.03.009 |
0.716 |
|
| 2016 |
Smits JA, Kauffman BY, Lee-Furman E, Zvolensky MJ, Otto MW, Piper ME, Powers MB, Rosenfield D. Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial. Contemporary Clinical Trials. PMID 27015966 DOI: 10.1016/J.Cct.2016.03.011 |
0.557 |
|
| 2016 |
Fillo J, Alfano CA, Paulus DJ, Smits JA, Davis ML, Rosenfield D, Marcus BH, Church TS, Powers MB, Otto MW, Baird SO, Zvolensky MJ. Emotion dysregulation explains relations between sleep disturbance and smoking quit-related cognition and behavior. Addictive Behaviors. 57: 6-12. PMID 26827153 DOI: 10.1016/J.Addbeh.2016.01.013 |
0.537 |
|
| 2016 |
Basden SL, Orr SP, Otto MW. Impaired De Novo Fear Conditioning in Opiate-Dependent Outpatients Cognitive Therapy and Research. 40: 824-830. DOI: 10.1007/S10608-016-9786-9 |
0.788 |
|
| 2015 |
Smits JA, Zvolensky MJ, Davis ML, Rosenfield D, Marcus BH, Church TS, Powers MB, Frierson GM, Otto MW, Hopkins LB, Brown RA, Baird SO. The Efficacy of Vigorous-Intensity Exercise as an Aid to Smoking Cessation in Adults With High Anxiety Sensitivity: A Randomized Controlled Trial. Psychosomatic Medicine. PMID 26513517 DOI: 10.1097/Psy.0000000000000264 |
0.574 |
|
| 2015 |
Moshier SJ, Szuhany KL, Hearon BA, Smits JA, Otto MW. Anxiety Sensitivity Uniquely Predicts Exercise Behaviors in Young Adults Seeking to Increase Physical Activity. Behavior Modification. PMID 26342011 DOI: 10.1177/0145445515603704 |
0.69 |
|
| 2015 |
Hofmann SG, Carpenter JK, Otto MW, Rosenfield D, Smits JA, Pollack MH. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. Contemporary Clinical Trials. 43: 223-30. PMID 26111923 DOI: 10.1016/J.Cct.2015.06.015 |
0.305 |
|
| 2015 |
Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects of physical activity on sleep: a meta-analytic review. Journal of Behavioral Medicine. 38: 427-49. PMID 25596964 DOI: 10.1007/S10865-015-9617-6 |
0.651 |
|
| 2015 |
Hofmann SG, Otto MW, Pollack MH, Smits JA. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Current Psychiatry Reports. 17: 532. PMID 25413638 DOI: 10.1007/S11920-014-0532-2 |
0.307 |
|
| 2014 |
Medina JL, DeBoer LB, Davis ML, Rosenfield D, Powers MB, Otto MW, Smits JA. Gender moderates the effect of exercise on anxiety sensitivity. Mental Health and Physical Activity. 7: 147-151. PMID 26617672 DOI: 10.1016/J.Mhpa.2014.08.002 |
0.564 |
|
| 2014 |
Otto MW, Hearon BA, McHugh RK, Calkins AW, Pratt E, Murray HW, Safren SA, Pollack MH. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. Journal of Psychoactive Drugs. 46: 402-11. PMID 25364993 DOI: 10.1080/02791072.2014.960110 |
0.78 |
|
| 2014 |
Moshier SJ, Landau AJ, Hearon BA, Stein AT, Greathouse L, Smits JA, Otto MW. The Development of a Novel Measure to Assess Motives for Compensatory Eating in Response to Exercise: The CEMQ. Behavioral Medicine (Washington, D.C.). 1-12. PMID 25148129 DOI: 10.1080/08964289.2014.955077 |
0.691 |
|
| 2014 |
Hearon BA, Quatromoni PA, Mascoop JL, Otto MW. The role of anxiety sensitivity in daily physical activity and eating behavior. Eating Behaviors. 15: 255-8. PMID 24854814 DOI: 10.1016/J.Eatbeh.2014.03.007 |
0.697 |
|
| 2014 |
Smits JA, Rosenfield D, Davis ML, Julian K, Handelsman PR, Otto MW, Tuerk P, Shiekh M, Rosenfield B, Hofmann SG, Powers MB. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial. Biological Psychiatry. 75: 840-6. PMID 24237691 DOI: 10.1016/J.Biopsych.2013.10.008 |
0.579 |
|
| 2014 |
Deckersbach T, Peters AT, Sylvia L, Urdahl A, Magalhães PV, Otto MW, Frank E, Miklowitz DJ, Berk M, Kinrys G, Nierenberg A. Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. The American Journal of Psychiatry. 171: 178-86. PMID 24077657 DOI: 10.1176/Appi.Ajp.2013.13020225 |
0.302 |
|
| 2013 |
McHugh RK, Reynolds EK, Leyro TM, Otto MW. An Examination of the Association of Distress Intolerance and Emotion Regulation with Avoidance. Cognitive Therapy and Research. 37: 363-367. PMID 32773909 DOI: 10.1007/s10608-012-9463-6 |
0.6 |
|
| 2013 |
McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. The Journal of Clinical Psychiatry. 74: 595-602. PMID 23842011 DOI: 10.4088/Jcp.12R07757 |
0.741 |
|
| 2013 |
McHugh RK, Murray HW, Hearon BA, Pratt EM, Pollack MH, Safren SA, Otto MW. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 18-22. PMID 23398222 DOI: 10.1111/J.1521-0391.2013.00317.X |
0.764 |
|
| 2013 |
Smits JA, Rosenfield D, Otto MW, Powers MB, Hofmann SG, Telch MJ, Pollack MH, Tart CD. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biological Psychiatry. 73: 1054-8. PMID 23332511 DOI: 10.1016/J.Biopsych.2012.12.009 |
0.693 |
|
| 2013 |
Asmundson GJ, Fetzner MG, Deboer LB, Powers MB, Otto MW, Smits JA. Let's get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depression and Anxiety. 30: 362-73. PMID 23300122 DOI: 10.1002/Da.22043 |
0.604 |
|
| 2013 |
Calkins AW, Hearon BA, Capozzoli MC, Otto MW. Psychosocial predictors of sleep dysfunction: the role of anxiety sensitivity, dysfunctional beliefs, and neuroticism. Behavioral Sleep Medicine. 11: 133-43. PMID 23136825 DOI: 10.1080/15402002.2011.643968 |
0.663 |
|
| 2013 |
Tart CD, Handelsman PR, Deboer LB, Rosenfield D, Pollack MH, Hofmann SG, Powers MB, Otto MW, Smits JA. Augmentation of exposure therapy with post-session administration of D-cycloserine. Journal of Psychiatric Research. 47: 168-74. PMID 23098672 DOI: 10.1016/J.Jpsychires.2012.09.024 |
0.588 |
|
| 2012 |
Smits JA, Zvolensky MJ, Rosenfield D, Marcus BH, Church TS, Frierson GM, Powers MB, Otto MW, Davis ML, DeBoer LB, Briceno NF. The efficacy of vigorous-intensity exercise as an aid to smoking cessation in adults with elevated anxiety sensitivity: study protocol for a randomized controlled trial. Trials. 13: 207. PMID 23148822 DOI: 10.1186/1745-6215-13-207 |
0.573 |
|
| 2012 |
McHugh RK, Weitzman M, Safren SA, Murray HW, Pollack MH, Otto MW. Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample. Journal of Psychoactive Drugs. 44: 237-42. PMID 23061323 DOI: 10.1080/02791072.2012.703507 |
0.537 |
|
| 2012 |
DeBoer LB, Powers MB, Utschig AC, Otto MW, Smits JA. Exploring exercise as an avenue for the treatment of anxiety disorders. Expert Review of Neurotherapeutics. 12: 1011-22. PMID 23002943 DOI: 10.1586/Ern.12.73 |
0.608 |
|
| 2012 |
Moshier SJ, McHugh RK, Calkins AW, Hearon BA, Rosellini AJ, Weitzman ML, Otto MW. The role of perceived belongingness to a drug subculture among opioid-dependent patients. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 26: 812-20. PMID 22732052 DOI: 10.1037/A0029107 |
0.753 |
|
| 2012 |
McHugh RK, Otto MW. Refining the measurement of distress intolerance. Behavior Therapy. 43: 641-51. PMID 22697451 DOI: 10.1016/j.beth.2011.12.001 |
0.564 |
|
| 2012 |
McHugh RK, Otto MW. Profiles of distress intolerance in a substance-dependent sample. The American Journal of Drug and Alcohol Abuse. 38: 161-5. PMID 22185368 DOI: 10.3109/00952990.2011.643990 |
0.581 |
|
| 2012 |
Hearon BA, Utschig AC, Smits JAJ, Moshier SJ, Otto MW. The Role of Anxiety Sensitivity and Eating Expectancy in Maladaptive Eating Behavior Cognitive Therapy and Research. 37: 923-933. DOI: 10.1007/S10608-012-9491-2 |
0.705 |
|
| 2012 |
Moshier SJ, Hearon BA, Calkins AW, Szuhany KL, Utschig AC, Smits JAJ, Otto MW. Clarifying the Link Between Distress Intolerance and Exercise: Elevated Anxiety Sensitivity Predicts Less Vigorous Exercise Cognitive Therapy and Research. 37: 476-482. DOI: 10.1007/S10608-012-9489-9 |
0.694 |
|
| 2011 |
McHugh RK, Daughters SB, Lejuez CW, Murray HW, Hearon BA, Gorka SM, Otto MW. Shared Variance among Self-Report and Behavioral Measures of Distress Intolerance. Cognitive Therapy and Research. 35: 266-275. PMID 23894216 DOI: 10.1007/S10608-010-9295-1 |
0.763 |
|
| 2011 |
McHugh RK, Otto MW. Domain-general and domain-specific strategies for the assessment of distress intolerance. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 25: 745-9. PMID 21823763 DOI: 10.1037/a0025094 |
0.562 |
|
| 2011 |
Weitzman ML, McHugh RK, Otto MW. The association between affect amplification and urgency. Depression and Anxiety. 28: 1105-10. PMID 21681865 DOI: 10.1002/da.20830 |
0.596 |
|
| 2011 |
McHugh RK, Rasmussen JL, Otto MW. Comprehension of self-report evidence-based measures of anxiety. Depression and Anxiety. 28: 607-14. PMID 21618668 DOI: 10.1002/da.20827 |
0.54 |
|
| 2011 |
McHugh RK, Hearon BA, Halperin DM, Otto MW. A novel method for assessing distress intolerance: adaptation of a measure of willingness to pay. Journal of Behavior Therapy and Experimental Psychiatry. 42: 440-6. PMID 21570933 DOI: 10.1016/J.Jbtep.2011.04.003 |
0.754 |
|
| 2011 |
Calkins AW, Deveney CM, Weitzman ML, Hearon BA, Siegle GJ, Otto MW. The effects of prior cognitive control task exposure on responses to emotional tasks in healthy participants. Behavioural and Cognitive Psychotherapy. 39: 205-20. PMID 21114896 DOI: 10.1017/S1352465810000652 |
0.68 |
|
| 2011 |
Hearon BA, Calkins AW, Halperin DM, McHugh RK, Murray HW, Otto MW. Anxiety sensitivity and illicit sedative use among opiate-dependent women and men. The American Journal of Drug and Alcohol Abuse. 37: 43-7. PMID 21090958 DOI: 10.3109/00952990.2010.535581 |
0.766 |
|
| 2010 |
Otto MW, McHugh RK, Kantak KM. Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes. Clinical Psychology : a Publication of the Division of Clinical Psychology of the American Psychological Association. 17: 91-103. PMID 26855480 DOI: 10.1111/j.1468-2850.2010.01198.x |
0.639 |
|
| 2010 |
Applebaum AJ, Bullis JR, Traeger LN, O'cleirigh C, Otto MW, Pollack MH, Safren SA. Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status. Neurobehavioral Hiv Medicine. 2010: 49-57. PMID 24062619 DOI: 10.2147/NBHIV.S12371 |
0.611 |
|
| 2010 |
Peckham AD, McHugh RK, Otto MW. A meta-analysis of the magnitude of biased attention in depression. Depression and Anxiety. 27: 1135-42. PMID 21049527 DOI: 10.1002/Da.20755 |
0.707 |
|
| 2010 |
McHugh RK, Murray HW, Hearon BA, Calkins AW, Otto MW. Attentional bias and craving in smokers: the impact of a single attentional training session. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 1261-4. PMID 20961974 DOI: 10.1093/Ntr/Ntq171 |
0.743 |
|
| 2010 |
McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. The Psychiatric Clinics of North America. 33: 511-25. PMID 20599130 DOI: 10.1016/J.Psc.2010.04.012 |
0.779 |
|
| 2010 |
Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behaviour Research and Therapy. 48: 720-7. PMID 20546699 DOI: 10.1016/J.Brat.2010.04.002 |
0.631 |
|
| 2010 |
Murray HW, McHugh RK, Rowley TC, Sirota AD, Otto MW. Development and validation of the smoking cue appeal survey. Substance Use & Misuse. 45: 2152-61. PMID 20469971 DOI: 10.3109/10826084.2010.481771 |
0.532 |
|
| 2010 |
Ocañez KL, McHugh RK, Otto MW. A meta-analytic review of the association between anxiety sensitivity and pain. Depression and Anxiety. 27: 760-7. PMID 20336798 DOI: 10.1002/da.20681 |
0.516 |
|
| 2010 |
Behar E, McHugh RK, Peckham A, Otto MW. D-cycloserine for the augmentation of an attentional training intervention for trait anxiety. Journal of Anxiety Disorders. 24: 440-5. PMID 20236791 DOI: 10.1016/J.Janxdis.2010.02.009 |
0.731 |
|
| 2010 |
McHugh RK, Behar E, Gutner CA, Geem D, Otto MW. Cortisol, stress, and attentional bias toward threat. Anxiety, Stress, and Coping. 23: 529-45. PMID 20191400 DOI: 10.1080/10615801003596969 |
0.533 |
|
| 2010 |
McHugh RK, Hofmann SG, Asnaani A, Sawyer AT, Otto MW. The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug and Alcohol Dependence. 108: 1-6. PMID 20060655 DOI: 10.1016/J.Drugalcdep.2009.11.017 |
0.526 |
|
| 2010 |
Applebaum AJ, Otto MW, Richardson MA, Safren SA. Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients Journal of Clinical and Experimental Neuropsychology. 32: 579-589. PMID 19890760 DOI: 10.1080/13803390903313572 |
0.527 |
|
| 2010 |
Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biological Psychiatry. 67: 365-70. PMID 19811776 DOI: 10.1016/J.Biopsych.2009.07.036 |
0.798 |
|
| 2010 |
Behar E, McHugh RK, Otto MW. Elucidating the Relationship between Worry and Physical Health Journal of Experimental Psychopathology. 1: jep.008210. DOI: 10.5127/Jep.008210 |
0.552 |
|
| 2009 |
McHugh RK, Smits JA, Otto MW. Empirically supported treatments for panic disorder. The Psychiatric Clinics of North America. 32: 593-610. PMID 19716992 DOI: 10.1016/j.psc.2009.05.005 |
0.612 |
|
| 2009 |
Calkins AW, Otto MW, Cohen LS, Soares CN, Vitonis AF, Hearon BA, Harlow BL. Psychosocial predictors of the onset of anxiety disorders in women: results from a prospective 3-year longitudinal study. Journal of Anxiety Disorders. 23: 1165-9. PMID 19699609 DOI: 10.1016/J.Janxdis.2009.07.022 |
0.713 |
|
| 2009 |
Powers MB, Smits JA, Otto MW, Sanders C, Emmelkamp PM. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. Journal of Anxiety Disorders. 23: 350-6. PMID 19223151 DOI: 10.1016/J.Janxdis.2009.01.001 |
0.577 |
|
| 2009 |
Otto MW, Basden SL, McHugh RK, Kantak KM, Deckersbach T, Cather C, Goff DC, Hofmann SG, Berry AC, Smits JA. Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants. Psychotherapy and Psychosomatics. 78: 49-54. PMID 19018157 DOI: 10.1159/000172620 |
0.763 |
|
| 2009 |
Bellack AS, Bowden CL, Bowie CR, Byerly MJ, Carpenter WT, Copeland LA, Dassori AM, Davis JM, Depp CA, Diaz E, Dixon LB, Docherty JP, Elbogen EB, Ghaemi SN, Keck PE, ... ... Otto M, et al. The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness Journal of Clinical Psychiatry. 70: 1-48. DOI: 10.4088/Jcp.7090Su1Cj |
0.321 |
|
| 2008 |
Murray H, McHugh RK, Behar E, Pratt E, Otto M. Personality factors associated with methadone maintenance dose. The American Journal of Drug and Alcohol Abuse. 34: 634-41. PMID 18821457 DOI: 10.1080/00952990802308163 |
0.59 |
|
| 2008 |
Smits JA, Berry AC, Rosenfield D, Powers MB, Behar E, Otto MW. Reducing anxiety sensitivity with exercise. Depression and Anxiety. 25: 689-99. PMID 18729145 DOI: 10.1002/Da.20411 |
0.6 |
|
| 2008 |
Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. The American Journal of Psychiatry. 165: 179-87. PMID 18198270 DOI: 10.1176/Appi.Ajp.2007.06111851 |
0.764 |
|
| 2008 |
Pollack MH, Otto MW, Roy-Byrne PP, Coplan JD, Rothbaum BO, Simon NM, Gorman JM. Novel treatment approaches for refractory anxiety disorders. Depression and Anxiety. 25: 467-76. PMID 17437259 DOI: 10.1002/Da.20329 |
0.318 |
|
| 2008 |
Smits JAJ, Powers MB, Berry AC, Otto MW. Translating empirically supported strategies into accessible interventions: The potential utility of exercise for the treatment of panic disorder Wiadomosci Psychiatryczne. 11: 300-313. DOI: 10.1016/J.Cbpra.2006.07.005 |
0.613 |
|
| 2007 |
McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW. Cost-efficacy of individual and combined treatments for panic disorder. The Journal of Clinical Psychiatry. 68: 1038-44. PMID 17685740 DOI: 10.4088/Jcp.V68N0710 |
0.573 |
|
| 2007 |
Otto MW, Basden SL, Leyro TM, McHugh RK, Hofmann SG. Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. Cns Spectrums. 12: 51-6, 59-61. PMID 17192764 DOI: 10.1017/S1092852900020526 |
0.796 |
|
| 2006 |
Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. Cns Drug Reviews. 12: 208-17. PMID 17227287 DOI: 10.1111/J.1527-3458.2006.00208.X |
0.32 |
|
| 2006 |
Davis M, Barad M, Otto M, Southwick S. Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches. Journal of Traumatic Stress. 19: 571-81. PMID 17075906 DOI: 10.1002/Jts.20149 |
0.385 |
|
| 2006 |
Otto MW, Simon NM, Powers M, Hinton D, Zalta AK, Pollack MH. Rates of isolated sleep paralysis in outpatients with anxiety disorders. Journal of Anxiety Disorders. 20: 687-93. PMID 16099138 DOI: 10.1016/J.Janxdis.2005.07.002 |
0.58 |
|
| 2006 |
Stathopoulou G, Powers MB, Berry AC, Smits JAJ, Otto MW. Exercise interventions for mental health: A quantitative and qualitative review Clinical Psychology: Science and Practice. 13: 179-193. DOI: 10.1111/J.1468-2850.2006.00021.X |
0.78 |
|
| 2005 |
Otto MW, Powers MB, Fischmann D. Emotional exposure in the treatment of substance use disorders: conceptual model, evidence, and future directions. Clinical Psychology Review. 25: 824-39. PMID 15967554 DOI: 10.1016/j.cpr.2005.05.002 |
0.6 |
|
| 2005 |
Otto MW, Deveney C. Cognitive-behavioral therapy and the treatment of panic disorder: Efficacy and strategies Journal of Clinical Psychiatry. 66: 28-32. PMID 15842185 |
0.317 |
|
| 2005 |
Otto MW, Powers M, Smits JAJ. Adding Cognitive-Behavioral Therapy to Pharmacotherapy for Panic Disorder: Issues and Strategies Cns Spectrums. 10: 32-39. DOI: 10.1017/S1092852900026523 |
0.604 |
|
| 2004 |
Simon NM, Otto MW, Smits JA, Nicolaou DC, Reese HE, Pollack MH. Changes in anxiety sensitivity with pharmacotherapy for panic disorder. Journal of Psychiatric Research. 38: 491-5. PMID 15380399 DOI: 10.1016/J.Jpsychires.2004.01.004 |
0.307 |
|
| 2004 |
Otto MW, Smits JA, Reese HE. Cognitive-behavioral therapy for the treatment of anxiety disorders. The Journal of Clinical Psychiatry. 65: 34-41. PMID 15078117 |
0.311 |
|
| 2004 |
Otto MW, Safren SA, Pollack MH. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. Journal of Anxiety Disorders. 18: 69-87. PMID 14725869 DOI: 10.1016/J.Janxdis.2003.07.007 |
0.32 |
|
| 2003 |
Rayburn NR, Otto MW. Cognitive-behavioral therapy for panic disorder: A review of treatment elements, strategies and outcomes Cns Spectrums. 8: 356-362. PMID 12766691 |
0.32 |
|
| 1998 |
Pollack M, Rapaport M, Clary C, Wolkow R, Mardekian J, Otto M, Nierenberg A. Early response to sertraline as a predictor of 12-week outcome in panic disorder European Neuropsychopharmacology. 8: S257. DOI: 10.1016/S0924-977X(98)80464-1 |
0.319 |
|
| 1997 |
Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis Behavior Therapy. 28: 285-305. DOI: 10.1016/S0005-7894(97)80048-2 |
0.327 |
|
| Show low-probability matches. |